Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancers

assignment_turned_inproject27 Aug 2011(Started)-26 Aug 2014(Ended)Closed

Funder: Institut National du CancerProject code: INCa-4016 Call for proposal: TRANSLA11

Funded under: TRANSLA

Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancers

- Summary
- DMPs

Partners

ENSMP , CNRS INSERM UMR144 , Centre National de la Recherche Scientifique , Groupe Hospitalier Henri Mondor - Albert Chenevier , Institut Curie

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::0f50f1941a491bca185d3abe14c332c3&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancers

Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancers

Loading